People: Discovery Laboratories Inc (DSCO.PH)

Summary

Name	Age	Since	Current Position
John Leone	65	2013	Independent Chairman of the Board
John Cooper	54	2013	President, Chief Executive Officer, Chief Financial Officer, Director
Thomas Miller	41	2010	Chief Operating Officer, Senior Vice President
Mary Templeton	65	2011	Senior Vice President, General Counsel and Corporate Secretary
Kathryn Cole	46	2006	Senior Vice President - Human Resources
Russell Clayton	51	2011	Senior Vice President - Research and Development
John Tattory	46	2010	Vice President - Finance, Principal Accounting Officer, Controller
Thomas Hoy	50	2010	Vice President - Manufacturing Operations
Michael Magee	51	2012	Vice President - Quality Operations
Joseph Mahady	59	2013	Director
Bruce Peacock	61	2013	Independent Director
Marvin Rosenthale	78	1998	Independent Director

» Insider Trading

Biographies

Name	Description
John Leone	Mr. John R. Leone has been appointed as the Independent Chairman of the Board of Discovery Laboratories, Inc. Mr. Leone was elected to the Board on November 13, 2012. Since 2007, Mr. Leone served as a partner of Paul Capital Healthcare, a private equity firm that manages one of the dedicated healthcare funds globally. From 2004 to 2006, Mr. Leone served as President and Chief Executive Officer at Cambrex Corporation, a publicly-traded life sciences company that provided innovative solutions for the development and commercialization of pharmaceutical products. Prior to that, Mr. Leone served as Senior Vice President and Chief Operating Officer of U.S. Commercial Operations for Aventis Pharmaceuticals, where he spearheaded the integration of Rhone-Poulenc Rorer and Hoechst Marion Roussell companies into Aventis, which required adjustments to staff, sophisticated technology and operating structures without any disruption in sales performance. Prior to that, Mr. Leone spent twelve years with American Home Products Corporation, where he most recently served as Vice President and General Manager of Wyeth-Lederle Vaccines and Pediatrics. Mr. Leon also spent ten years with Pfizer, most recently as Director of Operations, Europe. Mr. Leone is also a member of the Board of Directors of ViroPharma Incorporated. He received his Bachelor of Science degree in Engineering from the U.S. Military Academy at West Point and his Masters in Business Administration from the University of Colorado.
John Cooper	Mr. John G. Cooper, CPA, has been appointed as the President, Chief Executive Officer, Chief Financial Officer, Director of Discovery Laboratories Inc. Mr. Cooper has served as the Company’s President and Chief Financial Officer since August 2010, having previously served as Executive Vice President, Chief Financial Officer and Treasurer beginning December 2002. Mr. Cooper has over 25 years of experience as an executive with emerging growth companies in the life sciences industry and has been responsible for managing public and private financings, strategic alliances, mergers and acquisitions, investor relations, strategic and financial planning, international financial operations and general business operations. Mr. Cooper is a Certified Public Accountant and received a Bachelor of Science degree in Commerce from Rider University.
Thomas Miller	Dr. Thomas F. Miller, Ph.D., MBA, is the Chief Operating Officer, Senior Vice President of Discovery Laboratories Inc. He joined the Company in August 2004 and, since August 2010, has served as Senior Vice President and Chief Operating Officer. Previously, from 2006 to 2010, Dr. Miller served as Senior Vice President, Commercialization and Corporate Development and, from 2004 to 2006, as Vice President, Worldwide Marketing. Prior to joining the Company Dr. Miller served as the Director of Global Biologics Strategic Marketing at Centocor, a Johnson & Johnson biotechnology company, where he was responsible for the development of global business strategy for emerging, niche-market products. Prior to that, Dr. Miller held commercial and scientifically-related positions of increasing responsibility at Pharmacia, BASF Pharma, and Pfizer. Dr. Miller received his a Bachelor of Science degree in Biology from Fairfield University, an Masters in Business Administration from Fairleigh Dickinson University, and a Ph.D. in cardio-respiratory physiology from Temple University School of Medicine.
Mary Templeton	Ms. Mary B. Templeton, Esq. is the Senior Vice President, General Counsel and Corporate Secretary of Discovery Laboratories Inc. She previously served as Senior Vice President and Deputy General Counsel from March 2006. Previously, Ms. Templeton was in private practice in New York and, prior to that, held senior legal positions in the financial services industry, serving as Senior Vice President, General Counsel and Corporate Secretary to The Charles Schwab Corporation, San Francisco, as Senior Vice President and General Counsel to The Sequor Group Inc., an affiliate of Security Pacific Corporation, in New York and Los Angeles, as Director of Investment Company Products at Charles Schwab & Co., Inc., San Francisco, and as Trust Officer of Bradford Trust Company, New York. Ms. Templeton received her undergraduate degree from Chatham University, where she is a member of the Board of Trustees, and a J.D. with High Honors from Rutgers University School of Law – Camden. She is a member of the Bar Associations of Pennsylvania and New York.
Kathryn Cole	Ms. Kathryn A. Cole is the Senior Vice President - Human Resources of Discovery Laboratories Inc. She joined the Company in January 2006 as Senior Vice President, Human Resources. Previously, Ms. Cole served as Vice President, Human Resources for Savient Pharmaceuticals Inc., a publicly-traded specialty pharmaceutical company, where she was responsible for creating and implementing the human resources strategy for the corporate office, commercial operations, and its former subsidiary, Rosemont Pharmaceuticals, LTD. of Leeds, United Kingdom. Ms. Cole has also held various human resource management positions with companies, including Cytogen Corporation, EpiGenesis Pharmaceuticals, and the Prudential Insurance Company of America. Ms. Cole received her undergraduate degree in Communication from Douglass College and her Master of Science degree in Industrial Relations and Human Resources from the Rutgers University School of Management and Labor Relations.
Russell Clayton	Mr. Russell Clayton, D.O., is the Senior Vice President - Research and Development of He previously served as Vice President, Research and Development, from June 2009 to October 2011; Vice President, Medical and Academic Affairs, from September 2007 to June 2009; and Vice President, Global Research and Development, from May 2006 to September 2007. Dr. Clayton joined the Company in December 2005 as Vice President of Medical Affairs. Dr. Clayton is currently responsible for Regulatory Affairs and Pre-Clinical Research. Dr. Clayton previously served, at Merck & Company, as Regional Medical Director, Medical and Scientific Affairs; and prior to that, as Director of International Regulatory Affairs. Dr. Clayton served as Attending Pulmonologist at the Children’s Hospital of Philadelphia (CHOP), where he was Director of the Asthma Program for the Division of Pulmonary Medicine and Associate Director for the Cystic Fibrosis Center. He has also served as Attending Pulmonologist at St. Christopher’s Hospital for Children in Philadelphia, and as Assistant Professor of Pediatrics at Temple University School of Medicine and the University of Pennsylvania School of Medicine. He has given over 100 invited presentations, both national and international, and has authored articles and chapters on a variety of topics in pediatric lung disease. Dr. Clayton received his Bachelor of Arts degree in Biology from La Salle College and his medical degree from the Philadelphia College of Osteopathic Medicine.
John Tattory	Mr. John A. Tattory is the Vice President - Finance, Principal Accounting Officer, Controller of Discovery Laboratories Inc. He has served as our Vice President, Finance since January 2008, and was also appointed Controller and assigned the additional responsibility of Principal Accounting Officer in July 2010. Previously, from May 2005 to January 2008, Mr. Tattory served as Director, Financial Planning & Analysis at Tyco International. Prior to joining Tyco, Mr. Tattory was employed at Bristol-Myers Squibb in a variety of financial roles of increasing responsibility, most recently as Finance Director, U.S. Primary Care; and at Ernst & Young LLP in the firm’s audit practice. Mr. Tattory is a certified public accountant and received a Bachelor of Science degree in Commerce from Rider University.
Thomas Hoy	Mr. Thomas C. Hoy has been appointed as the Vice President - Manufacturing Operations of Discovery Laboratories, Inc., since September 2010. Previously, Mr. Hoy was employed by Johnson & Johnson for more than 22 years in roles of increasing responsibility in Manufacturing Operations, most recently as Executive Director, Worldwide Manufacturing (2008 – 2009), a strategic staff position with responsibility to leverage and harmonize Johnson & Johnson’s worldwide biotech manufacturing operations, and, before that, as General Manager, Malvern Operations (2006-2007), where he managed a high-profile bulk biological manufacturing site with more than 500 employees supporting worldwide sales of almost $2 billion. Prior to that, Mr. Hoy served as site General Manager for two other Pharmaceutical and Biotech Manufacturing Facilities as well as General Manager for Johnson & Johnson’s Worldwide Biological Contract Manufacturing Organization, which supported sales of more than $3 billion. Mr. Hoy received his Bachelor of Science degree in Pharmacy from Philadelphia College of Pharmacy and Science and his Masters of Business Administration in Operations Management from Drexel University.
Michael Magee	Mr. Michael L. Magee is the Vice President - Quality Operations of Discovery Laboratories, Inc. since May 2012, having previously served as Executive Director, Quality Operations since joining the Company in June 2011. Previously, Mr. Magee was employed by Johnson & Johnson for more than 23 years in roles of increasing responsibility, most recently in Global Technical Services as Principal Scientist, Parenteral Platform Technology (2009-2011) with responsibility for global technical transfer, new product introductions, and marketed product support, and previously as Site Quality Director, Raritan Operations (2004-2009) with responsibility for biopharmaceutical manufacturing plant quality operations supplying greater than 50 global markets. Prior to that, Mr. Magee held leadership roles in Quality Assurance, Process Excellence, Validation, Manufacturing Operations, and Plant Management. Mr. Magee received his Bachelor of Science degree in Chemistry from Moravian College and his Bachelor of Science degree in Pharmacy from the Philadelphia College of Pharmacy and Science(University of the Sciences in Philadelphia). Mr. Magee has more than 25 years of drug product development, technical service, manufacturing, and quality operations experience across diverse platforms and technologies. His management and health authority compliance responsibilities have included the implementation of robust quality management systems.
Joseph Mahady	Mr. Joseph M. Mahady has been appointed as the Director of Discovery Laboratories, Inc. Mr. Mahady brings global biopharmaceutical strategic, financial and operational to the Board, having spent over 30 years with Wyeth corporation. Most recently, Mr. Mahady served as President – Wyeth Pharmaceuticals, and prior to that as President, Global Business and President, Americas & Global Businesses at Wyeth. His other positions at Wyeth have included President Wyeth-Ayerst US, and Vice President Marketing and Sales Operations. Prior to his appointment to the Board, Mr. Mahady was not a related person to the Company and there is no transaction or other arrangement involving the Company in which Mr. Mahady or any related person to Mr. Mahady has or will have a direct or indirect material interest. Mr. Mahady will serve as a member of the Audit and Compensation Committees of the Board. Mr. Mahady is also a member of the Board of Directors of Albemarle Corporation and Cortendo, AB. He received his Bachelor of Science in Pharmacy from St. John’s University of Pharmacy and his Masters in Business Administration, Pharmaceutical Studies, from Fairleigh Dickinson University.
Bruce Peacock	Mr. Bruce A. Peacock is an Independent Director of Discovery Laboratories, Inc. Mr. Peacock has served as a member of the Board since September 2010. Since May 2006, Mr. Peacock has served as a Venture Partner with SV Life Sciences Advisors, LLC. Since September 2010, Mr. Peacock has served as Chief Business Officer of Ophthotech Corporation. He also serves as a Director and Co-Chairman of Alba Therapeutics and served as President and Chief Executive Officer from April 2008 to February 2011. Prior to joining SV Life Sciences Advisors, LLC, he served as Chief Executive Officer and director of The Little Clinic, a medical care services company. Previously, Mr. Peacock served as President and Chief Executive Officer and a director of Adolor Corporation, a publicly-held biotechnology company; as President, Chief Executive Officer and Director of Orthovita, Inc., a publicly-held orthopaedic biomaterials company; as Executive Vice President, Chief Operating Officer and Director of Cephalon, Inc.; and as Chief Financial Officer of Centocor, Inc. Mr. Peacock serves as a member of the board of directors of Ocean Power Technologies, Inc. and has served as a member of the boards of directors of Pharmacopeia, Inc. (2004-2008), Ligand Pharmaceuticals Incorporated (2008-2009), and NeurogesX, Inc. (2007-2009). Mr. Peacock earned a bachelor’s degree in Business Administration from Villanova University and is a certified public accountant.
Marvin Rosenthale	Dr. Marvin E. Rosenthale, Ph.D. is Independent Director of Discovery Laboratories Inc., since 1998. Prior to his retirement in 1999, Dr. Rosenthale served as President and Chief Executive Officer of Allergan Ligand Retinoid Therapeutics, Inc., having joined as Vice President in 1993. Previously, over a period of 16 years, Dr. Rosenthale served in a variety of executive positions at Johnson & Johnson, including Vice President, Drug Discovery Worldwide, at R.W. Johnson Pharmaceutical Research Institute, and director of the divisions of pharmacology and biological research and Executive Director of Drug Discovery Research at Ortho Pharmaceutical. Prior to that, Dr. Rosenthale served in various positions with Wyeth Laboratories. Dr. Rosenthale has previously served on the boards of directors of NuRx Pharmaceuticals Inc. (2008-2010), Radiant Pharmaceuticals Corp. (formerly AMDL, Inc., 2000-2006) and Allergan Specialty Therapeutics, Inc. (1998-2000), and currently serves on the boards of directors of two privately-held companies. Dr. Rosenthale received a Ph.D. in pharmacology from Hahnemann Medical College, an M.Sc. in pharmacology from Philadelphia College of Pharmacy & Science and a B.Sc. in pharmacy from the Philadelphia College of Pharmacy & Science.

Basic Compensation

Name	Fiscal Year Total
John Leone	--
John Cooper	721,625
Thomas Miller	648,600
Mary Templeton	--
Kathryn Cole	--
Russell Clayton	--
John Tattory	--
Thomas Hoy	--
Michael Magee	--
Joseph Mahady	--
Bruce Peacock	--
Marvin Rosenthale	--

As Of 30 Dec 2011

Options Compensation

Name	Options	Value
John Leone	0	0
John Cooper	745,000	1,448,653
Thomas Miller	0	0
Mary Templeton	0	0
Kathryn Cole	0	0
Russell Clayton	0	0
John Tattory	0	0
Thomas Hoy	0	0
Michael Magee	0	0
Joseph Mahady	0	0
Bruce Peacock	0	0
Marvin Rosenthale	0	0

Insider Trading

Name	Shares Traded	Price
LEONE JOHN R	3,000	$2.88
COLE KATHRYN A	2,014	$2.11
TATTORY JOHN ANDREW	1,849	$2.11
MILLER THOMAS F	2,014	$2.11
TEMPLETON MARY B	1,956	$2.11
COOPER JOHN G	2,014	$2.11
AMICK W THOMAS	2,015	$2.11
HOY THOMAS	2,014	$2.11
MAGEE MICHAEL L	2,014	$2.11
CLAYTON RUSSELL	2,015	$2.11
COLE KATHRYN A	1,497	$2.84
TEMPLETON MARY B	1,452	$2.84
AMICK W THOMAS	1,496	$2.84
COOPER JOHN G	1,496	$2.84
HOY THOMAS	1,497	$2.84
MILLER THOMAS F	1,496	$2.84
CLAYTON RUSSELL	1,496	$2.84
MAGEE MICHAEL L	1,497	$2.84
TATTORY JOHN ANDREW	1,373	$2.84
MAGEE MICHAEL L	1,832	$2.32
TATTORY JOHN ANDREW	1,681	$2.32
COOPER JOHN G	1,831	$2.32
COLE KATHRYN A	1,831	$2.32
TEMPLETON MARY B	1,778	$2.32
CLAYTON RUSSELL	1,832	$2.32

» Full list on Insider Trading

People: Discovery Laboratories Inc (DSCO.PH)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: